Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
RxSight, Inc.

RxSight, Inc. (RXST) Stock Overview

Explore RxSight, Inc.’s financial performance, market position, analyst ratings, and future outlook.

RXST●NASDAQ
HealthcareMedical - Devices
$7.01
$0.05(0.71%)
U.S. Market opens in 3h 5m

RxSight, Inc. (RXST)

Meyka AI Score

Z

Key Financials

Market Cap290.2M
P/E Ratio-6.20
EPS (TTM)$-0.93
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$8.61
3 Months$12.01
1 Year Target$0.00

RXST Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of RxSight, Inc. (NASDAQ: RXST) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, RxSight, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RXST on the NASDAQ shows an RSI of 71.12, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind RxSight, Inc.'s NASDAQ-traded stock include a P/E ratio of -6.20 and a market capitalization of 290.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of RXST on the NASDAQ.

Price Performance (NASDAQ: RXST)

1-Day Change
-0.71%
5-Day Change
16.25%
1-Month Change
38.54%
3-Month Change
26.31%
6-Month Change
-12.81%
Year-to-Date (YTD) Change
-32.73%
1-Year Change
-15.64%
3-Year Change
-76.29%
5-Year Change
-43.15%
All-Time (Max) Change
-56.19%

Contact Information

https://www.rxsight.com
949 521 7830
100 Columbia, Aliso Viejo, CA, 92656

Company Facts

4,610 Employees
IPO DateJul 30, 2021
CountryUS
Actively Trading

Frequently Asked Questions